<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Focal dermal hypoplasia (Goltz syndrome)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Focal dermal hypoplasia (Goltz syndrome)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Focal dermal hypoplasia (Goltz syndrome)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Timothy J Fete, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Dorothy K Grange, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1294408993"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Focal dermal hypoplasia (FDH; MIM #305600), also known as Goltz syndrome or Goltz-Gorlin syndrome, is an X-linked dominant multisystem disorder that is lethal in utero in males [<a href="#rid1">1</a>]. The primary feature of FDH is patchy dermal hypoplasia, with herniation of fat through defects in the dermis. There are a number of associated anomalies, including dental, hair, nails, extremities, central nervous system (CNS), and facial clefting.</p><p>This topic will discuss the pathogenesis, clinical manifestations, diagnosis, and treatment of FDH. Other ectodermal dysplasias are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/110146.html" rel="external">"Ectodermal dysplasias"</a> and  <a class="medical medical_review" href="/z/d/html/117131.html" rel="external">"Tumor protein p63 (TP63)-related ectodermal dysplasias"</a>.)</p><p class="headingAnchor" id="H545717442"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Focal dermal hypoplasia (FDH) is a very rare disorder. Its incidence and prevalence are not known. Approximately 300 cases have been reported in the literature since the first description in 1962 [<a href="#rid2">2</a>]. Approximately 90 percent of affected individuals are females.</p><p class="headingAnchor" id="H3862213860"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Focal dermal hypoplasia (FDH) is an X-linked dominant disorder caused by mutations or deletions in the porcupine O-acyltransferase gene (<em>PORCN</em>), located at Xp11.23. Over 200 variants of <em>PORCN</em> have been identified [<a href="#rid3">3</a>]. In mice and <em>Drosophila</em>,<em> </em>the protein product of <em>PORCN</em> has been shown to be required for the secretion of Wnt proteins, which are needed for the activation of target genes in many developmental pathways [<a href="#rid4">4-6</a>].</p><p>Approximately 90 percent of individuals with FDH are females. They are heterozygous or mosaic for a pathogenic variant in <em>PORCN</em>. Of the affected females, 95 percent have a de novo mutation, and 5 percent inherit the gene defect from a parent. The mosaic distribution of skin lesions in females reflects lyonization. </p><p>Males with FDH are mosaic for a de novo <em>PORCN</em> pathogenic mutation or may have Klinefelter syndrome with a 47,XXY karyotype. Hemizygosity for a pathogenic variant in <em>PORCN</em> is believed to be lethal in male fetuses [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H2631584067"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H53675075"><span class="h2">Cutaneous</span><span class="headingEndMark"> — </span>Patchy skin atrophy with fat herniation, typically following the lines of Blaschko, is a constant finding and is reported at birth in nearly 75 percent of affected individuals (<a class="graphic graphic_picture graphicRef55714 graphicRef110238" href="/z/d/graphic/55714.html" rel="external">picture 1A-B</a>) [<a href="#rid7">7</a>]. Atrophic areas are susceptible to recurrent or persistent, punctate, crusted erosions. The hypoplastic lesions typically become hypopigmented, often with hyperpigmented freckling and/or telangiectasias within the hypoplastic lesions.</p><p>Hyperpigmentation or hypopigmentation follow the lines of Blaschko (<a class="graphic graphic_picture graphicRef117104" href="/z/d/graphic/117104.html" rel="external">picture 2</a>). Papillomas are reported in nearly two-thirds of individuals, occurring primarily in the perioral area, groin, and distal extremities. Patchy alopecia and/or diffusely, sparse scalp hair is common. One cross-sectional survey noted that the majority of subjects reported skin or scalp symptoms of pruritus, stinging, and tenderness [<a href="#rid8">8</a>]. Nail changes are common, including longitudinal ridging, micronychia, and anonychia.</p><p class="headingAnchor" id="H2007864321"><span class="h2">Extracutaneous</span><span class="headingEndMark"> — </span>There are a variety of craniofacial manifestations associated with focal dermal hypoplasia (FDH), including microcephaly, facial asymmetry, notched nasal alae, cleft lip/palate, ocular abnormalities, dental anomalies, and dental malocclusions [<a href="#rid9">9</a>].</p><p>Oral soft tissue defects occur in approximately 70 percent of subjects and hard oral tissue defects in over 90 percent. More than one-half of patients have vertical dental enamel grooving, peg-shaped teeth, and/or enamel hypoplasia.<strong> </strong>Some patients are reported to have cleft lip/palate. </p><p>Intraoral lipomas or papillomas are common. Papillomas can also develop in the nose, pharynx, larynx, trachea, and esophagus [<a href="#rid10">10</a>]. There is one case report of squamous cell carcinoma of the esophagus [<a href="#rid11">11</a>]. Speech problems or difficulty chewing have been reported in up to three-fourths of individuals.</p><p>Limb abnormalities occur in over one-half of individuals with FDH [<a href="#rid12">12</a>]. Syndactyly and ectrodactyly are each reported in roughly two-thirds of affected individuals. Leg length discrepancy and reduction defects of long bones each occur in over one-half of affected individuals. Other reported orthopedic anomalies include congenital absence of foot and ankle, giant cell tumor of the bone, and osteopathia striata (striated appearance of bones on radiographs).</p><p>Short stature and low body weight are reported in up to three-fourths of affected individuals [<a href="#rid13">13</a>]. One study suggests growth hormone deficiency in a minority of patients [<a href="#rid14">14</a>]. Difficulty with feedings, chewing problems, and difficulty with swallowing are commonly reported, as are gastroesophageal reflux, gastroparesis, and constipation. Diaphragmatic hernia, hiatal hernia, umbilical hernia, and omphalocele have been reported.</p><p>Three-fourths of patients report ophthalmologic problems, including coloboma of the iris, retina, or choroid in over one-half of patients [<a href="#rid15">15</a>]. Nearly one-half have microphthalmia and 10 percent have anophthalmia. Additional ocular findings include coloboma, cataracts, nystagmus, and strabismus, as well as papillomas of the eyelid and conjunctiva. Vision ranges from 20/20 to only light perception.</p><p>Central nervous system manifestations can include sensorineural hearing loss, hydrocephalus, agenesis of the corpus callosum, and Arnold-Chiari malformation (see  <a class="medical medical_review" href="/z/d/html/6174.html" rel="external">"Hydrocephalus in children: Physiology, pathogenesis, and etiology", section on 'Congenital'</a> and  <a class="medical medical_review" href="/z/d/html/13507.html" rel="external">"Chiari malformations"</a>). Overall, adaptive and intellectual function is reported as average, with significant variability [<a href="#rid16">16</a>]. Approximately 15 percent of individuals are reported to have cognitive ability in the borderline to impaired range and 50 percent need educational support at school. Behavioral and emotional problems, usually withdrawn, shy behavior, are common. </p><p>Urogenital anomalies most commonly observed in affected girls are labia minora hypoplasia and short perineum body [<a href="#rid17">17</a>]. Asymmetry of the breast/nipples occur in one-third of individuals. There are case reports of bicornuate uterus, unilateral absent kidney, hypoplastic kidney, fused/horseshoe kidney, or cystic renal dysplasia. (See  <a class="medical medical_review" href="/z/d/html/5418.html" rel="external">"Congenital uterine anomalies: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"</a>.)</p><p class="headingAnchor" id="H2977552603"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Histopathologic findings in areas of dermal hypoplasia include increased capillaries in the papillary dermis, attenuated dermis, and adipocytes within/below the attenuated dermis [<a href="#rid18">18</a>]. A decrease and fragmentation of elastic fibers may represent histopathologic clues to the diagnosis of focal dermal hypoplasia (FDH), and FDH should be included in the differential diagnoses of elastolytic disorders. The absence of dermal hypoplasia does not exclude the diagnosis of FDH [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H4204347383"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Proposed clinical diagnostic criteria for focal dermal hypoplasia (FDH) include at least three of the major characteristic skin findings and one major limb malformation [<a href="#rid20">20</a>].</p><p>Major skin findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital patchy skin aplasia </p><p class="bulletIndent1"><span class="glyph">●</span>Congenital nodular fat herniation </p><p class="bulletIndent1"><span class="glyph">●</span>Congenital hyper- or hypopigmentation in Blaschko-linear distribution</p><p class="bulletIndent1"><span class="glyph">●</span>Telangiectasia </p><p class="bulletIndent1"><span class="glyph">●</span>Congenital ridged dysplastic nails</p><p></p><p>Major limb malformations:</p><p class="bulletIndent1"><span class="glyph">●</span>Split hand/foot (ectrodactyly)</p><p class="bulletIndent1"><span class="glyph">●</span>Transverse limb defects</p><p class="bulletIndent1"><span class="glyph">●</span>Syndactyly</p><p class="bulletIndent1"><span class="glyph">●</span>Oligodactyly</p><p class="bulletIndent1"><span class="glyph">●</span>Marked long bone reduction</p><p></p><p>Prenatal clinical findings suggesting possibility of FDH are the association of intrauterine growth retardation or low average weight, limb malformations, and thoracoabdominal wall defect or diaphragmatic hernia [<a href="#rid21">21</a>].</p><p>The diagnosis is confirmed by the identification of a germline heterozygous <em>PORCN</em> pathogenic variant or deletion in a female or a somatic mosaic hemizygous <em>PORCN</em> pathogenic variant in a male [<a href="#rid1">1</a>]. Genetics experts recommend sequence analysis of <em>PORCN</em> on a blood sample as first-tier testing. If no pathogenic variant is identified, intragenic deletion/duplication analysis of <em>PORCN</em> should be performed as well as chromosome microarray analysis to detect larger deletions/duplications that include <em>PORCN </em>[<a href="#rid1">1</a>].</p><p>If the suspicion for FDH is high, additional testing should include <em>PORCN</em> sequencing and deletion/duplication analysis on deoxyribonucleic acid (DNA) from saliva, a buccal swab, or an affected tissue (eg, skin, papillomas, surgical specimens), which increases the sensitivity for detecting somatic mosaicism [<a href="#rid22">22</a>]. Sanger sequencing alone may miss mosaic variants. Next-generation sequencing is more likely to allow for the detection of low-level mosaicism, especially in females with minimal clinical manifestations [<a href="#rid22">22</a>]. If this testing does not reveal a <em>PORCN</em> variant or deletion, a multigene panel that includes <em>PORCN</em> and other genes of interest may be considered. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Affected individuals with somatic mosaicism may also have germline mosaicism and are at risk of having affected offspring. Genetic counseling should be offered regarding recurrence risk and prenatal testing. Preimplantation genetic testing is also an option.</p><p class="headingAnchor" id="H340587861"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of focal dermal hypoplasia (FDH) includes [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear skin defects with multiple congenital anomalies 1</strong> – Linear skin defects with multiple congenital anomalies 1, also called microphthalmia with linear skin defects (MLS; MIM #309801) syndrome, can present with skin and eye findings similar to FDH, but limb and skeletal deformities are uncommon. It is caused by deletions and variants in the mitochondrial holocytochrome c-type synthase gene <em>HCCS</em> on Xp22.2.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incontinentia pigmenti</strong> – Incontinentia pigmenti (IP; MIM #308300) affects skin, hair, teeth, nails, eyes, and the central nervous system but rarely has skeletal findings. IP is due to mutation in <em>IKBKG </em>(<em>NEMO</em>) on Xq28. (See  <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">"Incontinentia pigmenti"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tumor protein p63-associated disorders</strong> – Tumor protein p63 (<em>TP63</em>)-associated disorders may have limb malformations and skin findings, but the skin findings are not typically along Blaschko distribution; ocular colobomas and microphthalmia are rare. <em>TP63</em> maps to 3q28. (See  <a class="medical medical_review" href="/z/d/html/117131.html" rel="external">"Tumor protein p63 (TP63)-related ectodermal dysplasias"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oculocerebrocutaneous syndrome</strong> – The primary features of oculocerebrocutaneous syndrome (Delleman syndrome; MIM #164180) are microphthalmia/anophthalmia, orbital cysts, and linear skin and dermal hypoplasia [<a href="#rid23">23,24</a>]. In contrast with FDH, this entity occurs primarily in males. Brain malformations (frontal microgyria, periventricular nodular heterotopia, agenesis of the corpus callosum) distinguish this condition from FDH.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rothmund-Thompson syndrome</strong> – Rothmund-Thompson syndrome (RTS; MIM #268400) is an autosomal recessive disorder due to pathogenic variants in <em>RECQL4</em> at 8q24.3 and characterized by poikiloderma, sparse hair, short stature, skeletal and dental anomalies, cataracts, and increased risk for cancer [<a href="#rid25">25</a>]. In contrast with FDH, in RTS, the skin lesions are typically not present at birth but develop over time. (See  <a class="medical medical_review" href="/z/d/html/15510.html" rel="external">"Kindler epidermolysis bullosa", section on 'Differential diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H1591656516"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of focal dermal hypoplasia (FDH) involves a multidisciplinary approach based upon the clinical findings in the individual patient [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cutaneous manifestations</strong> – Close follow-up by a dermatologist to manage erosive lesions and cutaneous papillomas is crucial.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway papillomas</strong> – Regular follow-up by a pediatric otolaryngologist to assess for airway papillomas, treatable with surgery or laser surgery, is indicated. Airway evaluation for papillomas is recommended prior to planned surgical procedures [<a href="#rid26">26,27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dental and oral manifestations</strong> – Assessment by a pediatric dentist by one year of age and potential management with orthodontic and prosthodontic specialists, as indicated. Cleft lip and/or palate management by plastic surgery and cleft team.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Growth and nutrition</strong> – Close follow-up by pediatrician, nutritionist, and possibly gastroenterology for feeding and growth problems. Endocrinology assessment for short stature, including consideration for testing for growth hormone deficiency.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ocular manifestations</strong> – Early eye examination for assessment and management of ocular abnormalities is indicated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limb and skeletal manifestations</strong> – Radiographic evaluation and consultation by orthopedic surgeon and/or plastic surgeon is appropriate.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal and urogenital anomalies</strong> – Renal ultrasound to assess for structural anomalies of the kidneys and collecting system. Evaluation by a pediatric gynecologist prior to puberty is recommended.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic manifestations</strong> – Hearing evaluation to rule out sensorineural or conductive hearing loss should be performed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cognitive development</strong> – Close monitoring for evidence of developmental delay and behavior issues, with management by developmental pediatrician; psychologist; and occupational, physical, or speech therapists, as indicated. </p><p></p><p>Information on FDH for patients and families/caregivers can be found online at the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Frarediseases.info.nih.gov%2Fdiseases%2F6457%2Ffocal-dermal-hypoplasia&amp;token=9E9IX7kiH9qRiTPgEvfhBWYEK1xv9pzeICuXRSzlhQpqQzomCGiYDVTfS5brjsUGwVnhSiEi0JlsPj9qaebp%2BffF8zBXWf8LD8xtukgqYRc%3D&amp;TOPIC_ID=117132" target="_blank">National Center for Advancing Translational Sciences</a> website. </p><p class="headingAnchor" id="H1770665236"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis for patients with focal dermal hypoplasia (FDH) is dependent upon the degree of involvement of cognitive function and neurosensory systems. Close monitoring of growth and development and multidisciplinary team management will improve outcomes.</p><p class="headingAnchor" id="H3209275228"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Focal dermal hypoplasia (FDH), also known as Goltz syndrome, is a rare X-linked dominant multisystem disorder characterized by patchy dermal hypoplasia and multiple cutaneous and extracutaneous abnormalities. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The mucocutaneous manifestations of FDH include patchy skin atrophy, often with crusted erosions, hypo- or hyperpigmented lesions that follow the lines of Blaschko, oral soft tissue defects, and papillomatosis of oropharyngeal and respiratory mucosa (<a class="graphic graphic_picture graphicRef55714 graphicRef110238" href="/z/d/graphic/55714.html" rel="external">picture 1A-B</a> and <a class="graphic graphic_picture graphicRef117104" href="/z/d/graphic/117104.html" rel="external">picture 2</a>). Extracutaneous manifestations include microcephaly, facial asymmetry, dental anomalies, cleft lip/palate, limb defects, ocular abnormalities, central nervous system abnormalities, and urogenital anomalies. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The clinical diagnosis of FDH in a neonate is based upon the finding of congenital major skin manifestations (eg, patchy skin aplasia, nodular fat herniation, dysplastic nails) and major limb malformations (eg, split hand/foot, syndactyly, oligodactyly). The diagnosis is confirmed by the identification of a germline heterozygous <em>PORCN</em> pathogenic variant or deletion in a female or somatic mosaic hemizygous <em>PORCN</em> pathogenic variant in a male. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – The management of FDH involves a multidisciplinary approach involving a pediatrician and pediatric dermatologist, otolaryngologist, dentist, plastic surgeon, ophthalmologist, neurologist, and geneticist, as indicated. (See <a class="local">'Management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Bostwick B, Van den Veyver IB, Sutton VR. Focal dermal hypoplasia. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.</li><li><a class="nounderline abstract_t">GOLTZ RW, PETERSON WC, GORLIN RJ, RAVITS HG. Focal dermal hypoplasia. Arch Dermatol 1962; 86:708.</a></li><li><a class="nounderline abstract_t">Lombardi MP, Bulk S, Celli J, et al. Mutation update for the PORCN gene. Hum Mutat 2011; 32:723.</a></li><li><a class="nounderline abstract_t">Tanaka K, Okabayashi K, Asashima M, et al. The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. Eur J Biochem 2000; 267:4300.</a></li><li><a class="nounderline abstract_t">Takada R, Satomi Y, Kurata T, et al. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 2006; 11:791.</a></li><li><a class="nounderline abstract_t">Liu W, Shaver TM, Balasa A, et al. Deletion of Porcn in mice leads to multiple developmental defects and models human focal dermal hypoplasia (Goltz syndrome). PLoS One 2012; 7:e32331.</a></li><li><a class="nounderline abstract_t">Bree AF, Grange DK, Hicks MJ, Goltz RW. Dermatologic findings of focal dermal hypoplasia (Goltz syndrome). Am J Med Genet C Semin Med Genet 2016; 172C:44.</a></li><li><a class="nounderline abstract_t">Gunasekera NS, Divito JK, Kupper TS, et al. Cross-Sectional Study Evaluating Skin, Hair, Nail, and Bone Disease in Patients with Focal Dermal Hypoplasia. Pediatr Dermatol 2017; 34:197.</a></li><li><a class="nounderline abstract_t">Wright JT, Puranik CP, Farrington F. Oral phenotype and variation in focal dermal hypoplasia. Am J Med Genet C Semin Med Genet 2016; 172C:52.</a></li><li><a class="nounderline abstract_t">Roberts ST, Shein G, Jacobson I. A Case of Focal Dermal Hypoplasia (Goltze Syndrome) Masquerading as Lingual Tonsillar Hypertrophy. Case Rep Otolaryngol 2019; 2019:9536256.</a></li><li><a class="nounderline abstract_t">Hafiz M, Sundaram S, Naqash AR, et al. A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome. ACG Case Rep J 2019; 6:1.</a></li><li><a class="nounderline abstract_t">Smith A, Hunt TR 3rd. The orthopedic characterization of Goltz syndrome. Am J Med Genet C Semin Med Genet 2016; 172C:41.</a></li><li><a class="nounderline abstract_t">Motil KJ, Fete M, Fete TJ. Growth, nutritional, and gastrointestinal aspects of focal dermal hypoplasia (Goltz-Gorlin syndrome). Am J Med Genet C Semin Med Genet 2016; 172C:29.</a></li><li><a class="nounderline abstract_t">Hsu SC, Bartz S, Pyle L, et al. Growth failure in focal dermal hypoplasia. Am J Med Genet A 2019; 179:628.</a></li><li><a class="nounderline abstract_t">Gisseman JD, Herce HH. Ophthalmologic manifestations of focal dermal hypoplasia (Goltz syndrome): A case series of 18 patients. Am J Med Genet C Semin Med Genet 2016; 172C:59.</a></li><li><a class="nounderline abstract_t">Deidrick KK, Early M, Constance J, et al. Cognitive and psychological functioning in focal dermal hypoplasia. Am J Med Genet C Semin Med Genet 2016; 172C:34.</a></li><li><a class="nounderline abstract_t">Adeyemi-Fowode OA, Mansouri R, Dietrich JE. Gynecologic findings in Goltz syndrome: A case series. Am J Med Genet C Semin Med Genet 2016; 172C:64.</a></li><li><a class="nounderline abstract_t">Ko CJ, Antaya RJ, Zubek A, et al. Revisiting histopathologic findings in Goltz syndrome. J Cutan Pathol 2016; 43:418.</a></li><li><a class="nounderline abstract_t">Rohdenburg C, Liersch J, Kutsche K, Schaller J. Fragmented Elastic Fibers in Focal Dermal Hypoplasia (Goltz-Gorlin Syndrome) Without Focal Dermal Hypoplasia: Report of a Male Case and Review of the Literature. Am J Dermatopathol 2020; 42:653.</a></li><li><a class="nounderline abstract_t">Bostwick B, Fang P, Patel A, Sutton VR. Phenotypic and molecular characterization of focal dermal hypoplasia in 18 individuals. Am J Med Genet C Semin Med Genet 2016; 172C:9.</a></li><li><a class="nounderline abstract_t">Mary L, Scheidecker S, Kohler M, et al. Prenatal diagnosis of focal dermal hypoplasia: Report of three fetuses and review of the literature. Am J Med Genet A 2017; 173:479.</a></li><li><a class="nounderline abstract_t">Heinz L, Bourrat E, Vabres P, et al. Mosaicism due to postzygotic mutations in women with focal dermal hypoplasia. Br J Dermatol 2019; 180:657.</a></li><li><a class="nounderline abstract_t">Delleman JW, Oorthuys JW. Orbital cyst in addition to congenital cerebral and focal dermal malformations: a new entity? Clin Genet 1981; 19:191.</a></li><li><a class="nounderline abstract_t">Moog U, Jones MC, Bird LM, Dobyns WB. Oculocerebrocutaneous syndrome: the brain malformation defines a core phenotype. J Med Genet 2005; 42:913.</a></li><li><a class="nounderline abstract_t">Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis 2010; 5:2.</a></li><li><a class="nounderline abstract_t">Ruzicki J, Nair GS, Wang A, et al. Papillomas in Goltz syndrome: case report, anaesthetic considerations, and review of the literature. Can J Ophthalmol 2019; 54:e227.</a></li><li><a class="nounderline abstract_t">Freethy A, Acharya V, Iacovidou A, Taghi A. Rare and unusual case of familial focal dermal hypoplasia (Goltz syndrome) presenting to otolaryngology in the UK. BMJ Case Rep 2019; 12.</a></li></ol></div><div id="topicVersionRevision">Topic 117132 Version 4.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bostwick B, Van den Veyver IB, Sutton VR. Focal dermal hypoplasia. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13948891" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Focal dermal hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21472892" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mutation update for the PORCN gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10866835" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17141155" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22412863" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Deletion of Porcn in mice leads to multiple developmental defects and models human focal dermal hypoplasia (Goltz syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26858134" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Dermatologic findings of focal dermal hypoplasia (Goltz syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28025844" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cross-Sectional Study Evaluating Skin, Hair, Nail, and Bone Disease in Patients with Focal Dermal Hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26843121" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Oral phenotype and variation in focal dermal hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31316852" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A Case of Focal Dermal Hypoplasia (Goltze Syndrome) Masquerading as Lingual Tonsillar Hypertrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31620495" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26867035" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The orthopedic characterization of Goltz syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27001925" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Growth, nutritional, and gastrointestinal aspects of focal dermal hypoplasia (Goltz-Gorlin syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30693654" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Growth failure in focal dermal hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27001926" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ophthalmologic manifestations of focal dermal hypoplasia (Goltz syndrome): A case series of 18 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26818018" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cognitive and psychological functioning in focal dermal hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27001927" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Gynecologic findings in Goltz syndrome: A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26956940" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Revisiting histopathologic findings in Goltz syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31789838" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Fragmented Elastic Fibers in Focal Dermal Hypoplasia (Goltz-Gorlin Syndrome) Without Focal Dermal Hypoplasia: Report of a Male Case and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26853229" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Phenotypic and molecular characterization of focal dermal hypoplasia in 18 individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27623003" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prenatal diagnosis of focal dermal hypoplasia: Report of three fetuses and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30022487" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mosaicism due to postzygotic mutations in women with focal dermal hypoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7273463" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Orbital cyst in addition to congenital cerebral and focal dermal malformations: a new entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15879499" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Oculocerebrocutaneous syndrome: the brain malformation defines a core phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20113479" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Rothmund-Thomson syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31564361" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Papillomas in Goltz syndrome: case report, anaesthetic considerations, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31811108" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Rare and unusual case of familial focal dermal hypoplasia (Goltz syndrome) presenting to otolaryngology in the UK.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
